24 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
anticoagulants (DOACs ... ) for VTE treatment ... #DOAC #Anticoagulants ... VTE #Management #Pharmacology ... #Comparison #Table
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
(DOAC interactions ... ) Cancer-treatment ... DOACs are substrates ... #Interactions #Table ... #Pharmacology
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
Management of DOACs ... interruption per treatment ... table ... Perioperative #Management #Treatment ... #pharmacology #
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
Drugs Used for the Treatment ... of COVID-19 Infection ... #Medications #Treatment ... #COVID19 #Pharmacology ... #Table #Management
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
for using anti-infectives ... IV to PO anti-infectives ... #pharmacology #antibiotics ... #medications #table ... #treatment #drugs
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
C virus (HCV) infection ... DAAs #Antivirals #table ... #treatment #hcv ... HepatitisC #Management #Pharmacology
Back to the "10 Need to Know" series - Drug Therapeutic Target Levels. 

For lithium, target
vary depending on treatment ... (0.5 - 0.8 ng/mL ... Ranges #Toxicology #Pharmacology ... #Diagnosis #Table
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... of COVID-19 Infection ... HCQ treatment would ... #COVID19 #Pharmacology ... #Table #Management
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... 100 cells/mm3 g/mL ... Treating Acute Infection ... IDSA #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... suspension 4–6 mL ... opportunistic #infections ... #HIVAIDS #pharmacology